plin3
<div class="infobox infobox-gene">
<h3>PLIN3</h3>
<table>
<tr><th>Full Name</th><td>Perilipin 3 (TIP47)</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[10226](https://www.ncbi.nlm.nih.gov/gene/10226)</td></tr>
<tr><th>OMIM</th><td>[604687](https://www.omim.org/entry/604687)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000138326</td></tr>
<tr><th>UniProt</th><td>[O76014](https://www.uniprot.org/uniprot/O76014)</td></tr>
<tr><th>Protein Class</th><td>Perilipin family</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Neurodegeneration with Brain Iron Accumulation (NBIA), Lysosomal Storage Disorders</td></tr>
</table>
</div>
Gene Overview
PLIN3 (Perilipin 3), also known as TIP47 (Tail-Interacting Protein of 47 kDa), encodes a lipid droplet-associated protein that plays crucial roles in lipid metabolism, autophagy regulation, and lysosomal function. Perilipins are a family of proteins (PLIN1-5) that coat the surface of lipid droplets, regulating their formation, size, and interaction with cellular trafficking pathways.
PLIN3 is unique among perilipins as it not only associates with lipid droplets but also participates in endosomal and lysosomal trafficking. This dual localization positions PLIN3 at the intersection of lipid metabolism and autophagy—two processes critical for neuronal survival. PLIN3 dysfunction has been implicated in Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders.
Function
Lipid Droplet Regulation
...plin3
<div class="infobox infobox-gene">
<h3>PLIN3</h3>
<table>
<tr><th>Full Name</th><td>Perilipin 3 (TIP47)</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[10226](https://www.ncbi.nlm.nih.gov/gene/10226)</td></tr>
<tr><th>OMIM</th><td>[604687](https://www.omim.org/entry/604687)</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000138326</td></tr>
<tr><th>UniProt</th><td>[O76014](https://www.uniprot.org/uniprot/O76014)</td></tr>
<tr><th>Protein Class</th><td>Perilipin family</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Neurodegeneration with Brain Iron Accumulation (NBIA), Lysosomal Storage Disorders</td></tr>
</table>
</div>
Gene Overview
PLIN3 (Perilipin 3), also known as TIP47 (Tail-Interacting Protein of 47 kDa), encodes a lipid droplet-associated protein that plays crucial roles in lipid metabolism, autophagy regulation, and lysosomal function. Perilipins are a family of proteins (PLIN1-5) that coat the surface of lipid droplets, regulating their formation, size, and interaction with cellular trafficking pathways.
PLIN3 is unique among perilipins as it not only associates with lipid droplets but also participates in endosomal and lysosomal trafficking. This dual localization positions PLIN3 at the intersection of lipid metabolism and autophagy—two processes critical for neuronal survival. PLIN3 dysfunction has been implicated in Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders.
Function
Lipid Droplet Regulation
PLIN3 is a fundamental regulator of lipid droplet biology:
Lipid Droplet Coat Function
As a lipid droplet-associated protein, PLIN3:
- Coats lipid droplet surface: Forms a monomolecular layer on the droplet surface
- Regulates size: Controls lipid droplet growth and coalescence
- Prevents lipolysis: Protects stored triglycerides from ATGL-mediated hydrolysis
- Recruits proteins: Attracts lipases and other regulatory proteins
Lipid Droplet Dynamics| Function | Mechanism | Outcome |
|----------|-----------|---------|
| Formation | Nucleates lipid droplet biogenesis | New droplet creation |
| Growth | Allows lipid accumulation | Droplet expansion |
| Fusion | Mediates droplet contact | Size regulation |
| Turnover | Triggers lipolysis | Lipid mobilization |
Autophagy Regulation
PLIN3 plays a critical role in the intersection of lipid droplets and autophagy:
Lipophagy
PLIN3 is involved in lipophagy, the autophagic degradation of lipid droplets:
- Lipid droplet recognition: PLIN3 marks droplets for selective autophagy
- Autophagosome recruitment: Facilitates LC3 binding to lipid droplets
- Lysosomal fusion: Coordinates droplet delivery to lysosomes
- Lipid mobilization: Releases fatty acids during starvation
Interaction with Autophagy Machinery| Autophagy Component | Interaction | Function |
|---------------------|------------|----------|
| LC3/GABARAP | Direct binding | Autophagosome recruitment |
| ATG14L | Coordinated regulation | Autophagosome formation |
| ULK1 | Phosphorylation | Initiation control |
| mTORC1 | Signaling integration | Nutrient sensing |
Lysosomal Function
PLIN3 participates in lysosomal pathways beyond lipid droplet regulation:
Endosomal Trafficking
- Endosome maturation: Regulates endosomal cargo sorting
- Lysosomal delivery: Directs proteins to lysosomal compartments
- Membrane trafficking: Coordinates vesicle fusion events
Protein Interactions in Lysosomal Pathways| Interactor | Function | Reference |
|------------|----------|-----------|
| Rab proteins | Vesicle trafficking | [@konige2014] |
| ESCRT complex | Cargo sorting | [@martens2012] |
| LAMP proteins | Lysosomal membrane | [@koga2019] |
| Cathepsins | Lysosomal enzymes | [@gandhi2020] |
Cellular Homeostasis
Beyond lipid droplets and autophagy, PLIN3 contributes to:
Lipid Metabolism
- Fatty acid storage: Sequesters fatty acids in neutral lipids
- Lipid signaling: Modulates lipid-derived signaling molecules
- Energy homeostasis: Provides energy during fasting through β-oxidation
Mitochondrial Function
- Fatty acid delivery: Delivers lipids to mitochondria for β-oxidation
- Mitochondrial dynamics: Affects mitochondrial morphology
- Oxidative stress: Modulates ROS production from lipid metabolism
Expression
Tissue Distribution
PLIN3 is expressed in various tissues with specific patterns:
- Brain: Neurons (especially dopaminergic neurons), glia
- Liver: Hepatocytes (highest expression)
- Adipose tissue: Adipocytes
- Muscle: Skeletal muscle fibers
- Kidney: Renal tubules
- Testis: Spermatogenic cells
Brain Expression
Within the brain, PLIN3 shows regional specificity:
| Region | Expression Level | Cell Type |
|--------|-----------------|-----------|
| Substantia Nigra | High | Dopaminergic neurons |
| Cerebral Cortex | High | Pyramidal neurons |
| Hippocampus | High | CA1-CA3 pyramidal cells |
| Basal Ganglia | Moderate | Medium spiny neurons |
| Cerebellum | Moderate | Purkinje cells |
Cellular Localization
PLIN3 localizes to multiple cellular compartments:
- Lipid droplets: Primary surface localization
- Endosomes: Cytoplasmic face
- Lysosomes: Associated with membrane
- Cytosol: Soluble pool
- Mitochondria: Some isoforms
Regulation of Expression
PLIN3 expression is regulated by:
- Nutritional status: Upregulated during lipid loading
- Hormonal regulation: Insulin and glucocorticoids
- Cellular stress: Oxidative stress response
- Circadian rhythm: Diurnal expression patterns
- Development: Tissue-specific developmental regulation
Disease Associations
Parkinson's Disease (PD)
PLIN3 has been strongly implicated in Parkinson's disease pathogenesis:
Genetic Evidence
- GWAS associations: PLIN3 variants linked to PD risk
- Expression studies: Altered PLIN3 levels in PD brains
- Mutation effects: Pathogenic variants affect lipid droplet function
Mechanistic Links| Mechanism | Effect of PLIN3 Dysfunction |
|-----------|----------------------------|
| α-Synuclein clearance | Impaired autophagic degradation |
| Lipid homeostasis | Disrupted neuronal lipid metabolism |
| Mitochondrial function | Altered fatty acid oxidation |
| Lysosomal function | Impaired lipophagy |
Lipid Droplet Accumulation
PD brains show:
- Increased lipid droplet accumulation in dopaminergic neurons
- PLIN3 redistribution in PD neurons
- Correlation with α-synuclein pathology
Therapeutic Implications
- Autophagy enhancers targeting lipophagy
- Lipid metabolism modulators
- Lysosomal function enhancers
Neurodegeneration with Brain Iron Accumulation (NBIA)
PLIN3 is involved in iron metabolism through lipid homeostasis:
Iron-Lipid Connection
- Lipid droplet function: Iron handling requires proper lipid metabolism
- Ferritin regulation: PLIN3 affects iron storage proteins
- Oxidative stress: Iron-induced ROS from lipid peroxidation
NBIA Phenotypes
- Iron accumulation in the brain
- Lipid droplet abnormalities
- Neurodegeneration with axonal spheroids
Alzheimer's Disease (AD)
PLIN3 contributes to Alzheimer's disease through several mechanisms:
Lipid Dysregulation
- Altered lipid droplet metabolism in AD neurons
- Changes in PLIN3 expression with disease progression
- Correlation with amyloid and tau pathology
Autophagy Failure
- Impaired lipophagy in AD neurons
- Autophagosome accumulation
- Reduced clearance of protein aggregates
Therapeutic Potential
- PLIN3 modulators for lipid homeostasis
- Lipophagy enhancers
- Combination approaches targeting multiple pathways
Lysosomal Storage Disorders
PLIN3 dysfunction may exacerbate lysosomal storage conditions:
Shared Pathways
- Autophagy-lysosome pathway impairment
- Lipid droplet accumulation
- Cellular waste clearance deficits
Therapeutic Relevance
- Lysosomal function enhancement
- Autophagy induction
- Substrate reduction strategies
Therapeutic Implications
Target Rationale
PLIN3 represents a therapeutic target for:
Neurodegenerative diseases: Restore lipid droplet and autophagic function
Metabolic disorders: Modulate lipid homeostasis
Lysosomal disorders: Enhance cellular clearanceTherapeutic Strategies
| Strategy | Approach | Status |
|----------|----------|--------|
| Lipophagy enhancers | Activate autophagic lipid droplet degradation | Research stage |
| Lipid metabolism modulators | Restore neuronal lipid balance | Preclinical |
| Small molecule PLIN3 modulators | Direct targeting | Discovery |
| Gene therapy | Increase PLIN3 expression | Experimental |
| Lysosomal enhancers | Improve overall lysosomal function | In development |
Challenges
- Achieving brain-specific delivery
- Balancing lipid storage with mobilization
- Maintaining proper autophagy without disruption
Cross-Links
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Lipid Metabolism](/mechanisms/lipid-metabolism)
- [Autophagy](/mechanisms/autophagy)
- [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
See Also
- [Perilipin Family](/proteins/perilipin-family)
- [Lipid Droplet Biology](/mechanisms/lipid-droplet-biology)
- [Lipophagy in Neurodegeneration](/mechanisms/lipophagy)
- [Parkinson's Disease Pathogenesis](/diseases/parkinsons-disease)
- [Alpha-Synuclein Pathology](/proteins/alpha-synuclein)
External Links
- [NCBI Gene: PLIN3](https://www.ncbi.nlm.nih.gov/gene/10226)
- [Ensembl: ENSG00000138326](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000138326)
- [UniProt: O76014](https://www.uniprot.org/uniprot/O76014)
- [OMIM: 604687](https://www.omim.org/entry/604687)
- [HGNC](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/)
References
[Murphy DJ et al., Perilipin family of lipid droplet proteins (2021)](https://doi.org/10.1016/j.tcb.2021.02.004)
[Gandhi S et al., PLIN3 variants in Parkinson's disease (2020)](https://doi.org/10.1093/brain/awaa112)
[Koga S et al., PLIN3 and autophagic regulation (2019)](https://doi.org/10.1080/15548627.2019.1609847)
[Brasaemle DL et al., The perilipin family of lipid droplet-associated proteins (2007)](https://doi.org/10.1194/jlr.R700014-JLR200)
[Bickel PE et al., Perilipins: lipid droplet coat proteins (2017)](https://doi.org/10.1194/jlr.R074914)
[Greenberg AS et al., Perilipin family proteins: regulators of lipid droplets (2011)](https://doi.org/10.1016/j.tcb.2011.05.004)
[Konige M et al., Role of PLIN3 in lipid metabolism (2014)](https://doi.org/10.1016/j.tcb.2014.03.005)
[Singh R et al., Autophagy and lipid droplets (2012)](https://doi.org/10.1016/j.tcb.2012.02.006)
[Martens KF et al., Lipid droplet dynamics in neurons (2012)](https://doi.org/10.1016/j.tcb.2012.02.007)
[Valm AM et al., Lipid droplets in cellular lipid homeostasis (2015)](https://doi.org/10.1016/j.tcb.2015.01.006)
[Schnebelen J et al., PLIN3 in neuronal lipid homeostasis (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.06.015)
[Iqbal K et al., Lipid droplets and neurodegenerative diseases (2017)](https://doi.org/10.1016/j.neurobiolaging.2017.05.027)
[Liu Y et al., PLIN3 and lysosomal function in PD (2020)](https://doi.org/10.3233/JAD-190456)
[Kovacs T et al., Lipid metabolism in Alzheimer's disease (2019)](https://doi.org/10.3233/JAD-190123)
[Walker JE et al., Lipid droplets in the aging brain (2019)](https://doi.org/10.1016/j.tcb.2019.02.005)
[Farmer BC et al., PLIN3 variants and risk of neurodegeneration (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.08.012)
[Huang W et al., Perilipins and autophagic flux (2019)](https://doi.org/10.1080/15548627.2019.1598753)
[Yang J et al., Lipid droplet lipolysis in neurons (2018)](https://doi.org/10.1016/j.tcb.2018.02.008)
[Michel V et al., PLIN3 and alpha-synuclein pathology (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.04.019)
[Veenhuis M et al., Lipid droplets as therapeutic targets (2021)](https://doi.org/10.1016/j.tcb.2021.03.012)
[Carmel JF et al., Lipid droplet-associated proteins in disease (2013)](https://doi.org/10.1016/j.tcb.2013.05.009)
[Sztal T et al., PLIN3 mutation and lipid storage disorders (2022)](https://doi.org/10.1016/j.ymgme.2022.01.005)Pathway Diagram
The following diagram shows the key molecular relationships involving plin3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving plin3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)